To address the ongoing COVID-19 related iodinated contrast media product shortage, Iomeron will be temporarily available in the US starting at the end of August 2022.
Diagnostic Agents
Fresenius Kabi Launches Generic Iodinated Contrast Media Agent to Alleviate Shortage
Due to COVID-19 related supply-chain disruptions, Iodixanol and other contrast media agents have been in shortage nationwide.
Bludigo Approved as Diagnostic Dye for Cystoscopic Assessment of Ureters
The approval was based on data from a phase 3 study that included 118 adults undergoing endoscopic urological or gynecological surgical procedures.
E-Noses Promising for Diagnosing Cancer from Exhaled Breath
Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer
Prevalence of CRC Screening Remains Low in Those Aged 50 to 54
Increase in screening differed by age, with 19.4 percent increase for those aged 50 to 54 and 31.6 percent increase for those aged 70 to 75
ASRA: Adjust Use of Contrast for Pain Procedures During Shortage
Consider the use of an alternative form of visualization, such as ultrasound, when feasible
Prenatal Exposure to Certain Antiseizure Meds Linked to Autism
Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies
Using New Guidelines Would Increase Diabetes Screening Eligibility
Screening eligibility would increase overall and among those with prediabetes with USPSTF 2021, ADA 2022 guidelines
FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
